Virios Therapeutics, Inc.Virios Therapeutics, Inc.Virios Therapeutics, Inc.

Virios Therapeutics, Inc.

No trades
See on Supercharts
Market capitalization
‪8.68 M‬USD
−0.2830USD
‪−5.30 M‬USD
‪14.86 M‬
Beta (1Y)
4.98

About Virios Therapeutics, Inc.

CEO
Gregory Duncan
Headquarters
Alpharetta
Website
Employees (FY)
4
Founded
2012
ISIN
US92829J1043
FIGI
BBG00X0SZKJ2
Virios Therapeutics, Inc. engages in pharmaceutical products for fibromyalgia and other related conditions. The firm engages in the development and commercialization of antiviral therapies to treat diseases associated with a viral triggered abnormal immune response including fibromyalgia. It offers IMC-1, a novel, proprietary, fixed dose combination of famciclovir and celecoxib. The company was founded by William L. Pridgen on February 28, 2012 and is headquartered in Alpharetta, GA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of VIRI is 0.45 USD — it has decreased by 0.24% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Virios Therapeutics, Inc. stocks are traded under the ticker VIRI.
Virios Therapeutics, Inc. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for Virios Therapeutics, Inc. has a max estimate of 0.40 USD and a min estimate of 0.40 USD.
VIRI earnings for the last quarter are −0.06 USD whereas the estimation was −0.09 USD which accounts for 33.33% surprise. Estimated earnings for the next quarter are −0.07 USD. See more details about Virios Therapeutics, Inc. earnings.
Yes, you can track Virios Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
VIRI stock has fallen by 1.98% compared to the previous week, the month change is a 44.47% rise, over the last year Virios Therapeutics, Inc. has showed a 30.84% decrease.
Like other stocks, VIRI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Virios Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
VIRI reached its all-time high on Dec 17, 2020 with the price of 16.71 USD, and its all-time low was 0.22 USD and was reached on Dec 28, 2022.
See other stocks reaching their highest and lowest prices.
As of Apr 18, 2024, the company has 4.00 employees. See our rating of the largest employees — is Virios Therapeutics, Inc. on this list?